HomeInsightsStock Comparison

Granules India Ltd vs Quest Laboratories Ltd Stock Comparison

Granules India Ltd vs Quest Laboratories Ltd Stock Comparison

Last Updated on: May 30, 2025

Key Highlights

  • The Latest Trading Price of Granules India Ltd is ₹ 531.2 as of 30 May 15:30.
  • The P/E Ratio of Granules India Ltd changed from 10.9 on March 2020 to 25.7 on March 2024 . This represents a CAGR of 18.71% over 5 yearsThe P/E Ratio of Quest Laboratories Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Granules India Ltd changed from ₹ 3650 crore on March 2020 to ₹ 10420 crore on March 2024 . This represents a CAGR of 23.34% over 5 yearsThe Market Cap of Quest Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Granules India Ltd for the Mar '25 is ₹ 1230 crore as compare to the Dec '24 revenue of ₹ 1143 crore. This represent the growth of 7.59% The revenue of Quest Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Granules India Ltd for the Mar '25 is ₹ 285.03 crore as compare to the Dec '24 ebitda of ₹ 235.97 crore. This represent the growth of 20.79% The ebitda of Quest Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Granules India Ltd changed from ₹ 47.9 crore to ₹ 152.03 crore over 8 quarters. This represents a CAGR of 78.15% The net profit of Quest Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Granules India Ltd changed from 5.72 % on March 2020 to 8.34 % on March 2024 . This represents a CAGR of 7.83% over 5 yearsThe Dividend Payout of Quest Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
  • With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.
  • It is also home to one of the World's largest Paracetamol API facilities. Company's research center at Pragathi Nagar, Hyderabad, spread across an area of 15,000 square feet, epitomizes the company's focus on research and development.

About Quest Laboratories Ltd

  • Quest Laboratories Ltd was originally incorporated under the name 'Quest Laboratories Private Limited' vide Certificate of Incorporation dated June 01, 1998, issued by the Registrar of Companies Madhya Pradesh, Gwalior.
  • Thereafter, the status of the Company changed to Public Limited and the name of Company was changed to 'Quest Laboratories Limited' vide fresh Certificate of Incorporation issued on January 23, 2024, by Registrar of Companies, Centralised Processing Centre. The Company is engaged in manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
  • These formulations fall under the trademark 'Quest Laboratories Limited'.

Granules India Ltd News Hub

News

Granules India to convene AGM

Granules India announced that the 34th Annual General Meeting(AGM) of the company will be ...

Read more

28 May 2025 14:10

News

Board of Granules India recommends final dividend

Granules India announced that the Board of Directors of the Company at its meeting held on...

Read more

28 May 2025 14:11

News

Granules India to declare Quarterly Result

Granules India will hold a meeting of the Board of Directors of the Company on 28 May 2025...

Read more

07 May 2025 11:42

News

Granules India completes acquisition of Swiss-based CDMO - Senn Chemicals AG

Granules India announced the successful closing of the acquisition of Senn Chemicals AG, a...

Read more

11 Apr 2025 10:15

News

Granules India allots 50,000 equity shares under ESOS

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025. Powered by C...

Read more

20 Mar 2025 19:46

News

Granules India Ltd Falls 3.02%

Granules India Ltd lost 3.02% today to trade at Rs 457.2. The BSE Healthcare index is down...

Read more

05 Mar 2025 09:30

Quest Laboratories Ltd News Hub

News

Quest Laboratories to hold board meeting

Quest Laboratories will hold a meeting of the Board of Directors of the Company on 28 May ...

Read more

24 May 2025 20:10

News

Quest Laboratories to hold board meeting

Quest Laboratories will hold a meeting of the Board of Directors of the Company on 27 Janu...

Read more

24 Jan 2025 12:58

News

Quest Laboratories to table results

Quest Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

07 Nov 2024 16:16

News

Quest Laboratories to convene AGM

Quest Laboratories announced that the 26th Annual General Meeting (AGM) of the company wil...

Read more

10 Aug 2024 17:23

News

NSE SME Quest Laboratories jumps on debut

The scrip was listed at Rs 155.10, a premium of 59.90% compared with the initial public of...

Read more

23 May 2024 11:19

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Quest Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Quest Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Granules India Ltd and Quest Laboratories Ltd

Which company has a larger market capitalization, Granules India Ltd or Quest Laboratories Ltd?

Market cap of Granules India Ltd is 12,883 Cr while Market cap of Quest Laboratories Ltd is 143 Cr

What are the key factors driving the stock performance of Granules India Ltd and Quest Laboratories Ltd?

The stock performance of Granules India Ltd and Quest Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Granules India Ltd and Quest Laboratories Ltd?

As of May 30, 2025, the Granules India Ltd stock price is INR ₹531.2. On the other hand, Quest Laboratories Ltd stock price is INR ₹87.45.

How do dividend payouts of Granules India Ltd and Quest Laboratories Ltd compare?

To compare the dividend payouts of Granules India Ltd and Quest Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions